LATISSE® (bimatoprost ophthalmic solution) 0.03% — the first and only FDA-approved eyelash growth treatment

Orlando Eye Care - LATISSE

Have you always wanted longer, fuller darker lashes? Dr. Love can help! LATISSE® (bimatoprost ophthalmic solution) 0.03% is the first and only prescription treatment approved by the FDA for inadequate or not having enough eyelashes, growing them longer, fuller and darker.

How It Works:

LATISSE® makes lash growth possible because of its active ingredient: bimatoprost. Although the precise mechanism of action is not known, research suggests that the growth of eyelashes occurs by increasing the percent of hairs in, and the duration of, the anagen (or growth) phase. Lashes can grow longer, thicker and darker because bimatoprost can also prolong this growth phase.

LATISSE® is FDA approved and effective. It's a once-a-day treatment you apply topically to the base of your upper eyelashes. Patients in a clinical trial saw results in as few as 8 weeks with full results after 12 to 16 weeks.

If you stop using LATISSE®, your eyelashes are expected to return to their previous appearance over several weeks to months.

Possible side effects:

The most common side effects after using LATISSE® solution are an itching sensation in the eyes and/or eye redness. This was reported in approximately 4% of patients. LATISSE® solution may cause other less common side effects which typically occur on the skin close to where LATISSE® is applied, or in the eyes. These include skin darkening, eye irritation, dryness of the eyes, and redness of the eyelids.

If you develop a new ocular condition (e.g., trauma or infection), experience a sudden decrease in visual acuity, have ocular surgery, or develop any ocular reactions, particularly conjunctivitis and eyelid reactions, you should immediately seek your physician's advice concerning the continued use of LATISSE® solution.

If you wear contacts:

Contact lenses should be removed prior to application of LATISSE® and may be reinserted 15 minutes following its administration. If Latisse gets in your eye, the eye should not be rinsed. Latisse solution is an opthalmic drug product, it is not expected to cause harm.

If you take certain medications:

LATISSE® may decrease IOP. This is a condition where the pressure inside the eye is higher than normal. Let Dr. Love know if you are using IOP-lowering medications. Concurrent administration of LATISSE® and certain IOP-lowering medications in ocular hypertensive patients should be closely monitored for changes in intraocular pressure.

Schedule a consultation:

For new patients, Dr. Love would like to see you for an Ocular Health check and a visual assessment. He would need to check you intraocular pressures and also discuss you medical history to be sure you are a good candidate for LATISSE®.